Surgicure Technologies
Techstars '24Charlestown, US · Founded 2018 · Delaware corporation · 10 employees on LinkedIn · 11 known investors
Find your way into Surgicure Technologies
2,839 people in our graph can introduce you to the Surgicure Technologies team.
Sign up to see every warm intro you have to Surgicure Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Surgicure Technologies team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Surgicure Technologies develops medical devices for airway management in civilian and military settings. The company's products help healthcare professionals reduce adverse events and improve patient outcomes through optimized breathing support and faster deployment.
Also known as Surgicure · Surgicure Technologies, Inc.
Founders & leadership
Surgicure Technologies was founded in 2018 by Irena King.

Board
Investors · 11
How we know: the VCSheet dataset · Not right? Tell us
How we know: research · finsmes.com · Not right? Tell us
How we know: research · finsmes.com · Not right? Tell us
How we know: the VCSheet dataset · research · finsmes.com · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Also in the syndicate · 5
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2024
▶$2.4MraisedFeb 2025 · 64 investors · Other Health CareRule 506(b)
- Irena KingExecutive Officer, Director, Promoter
- David PierceDirector
- Carl WinfreeDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- Minimum investment
- $10K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Sep 2026Surgicure Technologies, Inc. is a privately held medical device company focused on airway management for civilian and military care settings. Its stated mission is to reduce adverse events by supplying devices that optimize patient breathing, improve deployment speed, and support safety and quality of care in critical situations.
The company's lead product is the HORSESHOE, a patented endotracheal tube (ETT) securement device. It uses an off-the-face, horseshoe-shaped design with a robust locking mechanism, integrated molar props, an internal support frame, a backup-strap D-ring, an ancillary tubing bracket for oral/nasogastric tubes and pilot balloon lines, and an adjustable track. The single adjustable size accommodates ET tubes from 6.5 to 10 mm and a range of patient circumstances including facial trauma, facial burns or pressure injuries, chemotherapy patients with TENS, patients with beards, and emaciated patients. Because the device does not rely on contact with facial skin or lips, adhesives, tape, or wires, the company positions it as reducing medical device related pressure injuries (MDRPIs) while allowing facial skin assessment and cleaning and faster tube repositioning with the device in place.
Marketed claims center on reducing unplanned extubations and tube dislodgement, maintaining tube stability with greater patient comfort, facilitating oral care without compromising airway security, and supporting compliance with 2022 ICHE ventilator-associated pneumonia prevention "Essential Practices" and international NPIAP MDRPI prevention guidelines.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsSeed financing of $1.785 million led by Launchpad Venture Group with major contribution from Gurtin Ventures and participation from BakerBridge Capital, TiE Angels, SBXi, Beacon Angels, SideCar Angels, Tidal River Fund and BBE Ventures. Proceeds are intended to accelerate commercialization of the HORSESHOE endotracheal tube securement device across critical care, burn/trauma, evacuation and transport settings.
$1.8M source ↗
TechCrunch selected Surgicure for its Startup Battlefield 200 biotech and pharma group, citing its patented endotracheal tube securement solution.
A Form D filing dated September 23, 2024 reported a first sale on September 6, 2024, a total offering amount of $2,112,315 and $1,692,315 sold as of the filing date, including conversion of $612,315 in outstanding convertible securities.
$1.7M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 8
primary sources listed
- Surgicure Technologiessurgicuretech.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Surgicure Technologies do?
- Medical device company developing the HORSESHOE patented endotracheal tube securement device for civilian and military airway management.
- Who founded Surgicure Technologies?
- Surgicure Technologies was founded by Irena King in 2018.
- Who are Surgicure Technologies's investors?
- Surgicure Technologies's investors include Bantam Group, Beacon Angels, Gurtin Ventures, Launchpad Venture Group, Techstars, SBXi.
- How much funding has Surgicure Technologies raised?
- Surgicure Technologies has disclosed $2.4M raised across 1 round.
- Where is Surgicure Technologies headquartered?
- Surgicure Technologies is headquartered in Charlestown, US.





